PharBioMed Life Sciences Private Limited was founded by industry experts with a vision to provide quality services to the BioPharma and MedTech industries, managing comprehensive clinical research and regulatory services throughout the compliance process. We strictly adhere to ICH Guidelines and applicable regulations, including EMA, US FDA, DCGI, EU MDR, and other statutory legal requirements.
Our 'Patients First' approach enables us to deliver end-to-end clinical data management, biostatistics and SAS programming, pharmacovigilance, medical writing, medical device, and IVD services — guided by our core values of excellence, passion, integrity, and commitment.
We pride ourselves on delivering exceptional services with top-notch quality while offering flexible timeframes and cost-effectiveness. Our global team comprises expert life sciences consultants who bring together medical, therapeutic, and scientific expertise to support BioPharma and MedTech companies in developing safe and high-quality drugs and devices.
To become a trusted CRO partner for BioPharma and MedTech companies in transforming patients' lives — combining scientific rigor, regulatory precision, and the next generation of AI-powered evidence intelligence.
To deliver exceptional clinical research and regulatory services with top-notch quality, cost-effectiveness, and efficiency. We achieve this through collaborative and synergistic partnerships founded on the principles of excellence, passion, integrity, and courage.
End-to-end clinical, regulatory, and AI-powered evidence intelligence — from data capture through commercialization.
CDISC-compliant CRF/eCRF design, EDC configuration, data validation, medical coding, and database lock — built for speed and quality.
Read More
SAP development, SDTM/ADaM datasets, statistical analyses, ISS/ISE, and submission-ready outputs across all therapeutic areas.
Read More
ICSR processing, aggregate safety reporting, signal detection, literature monitoring, and QPPV services — GVP-aligned.
Read More
ICH E3 compliant CSRs, IBs, protocols, IMPDs, NDAs/MAAs, patient narratives, and regulatory submission documents.
Read More
EU MDR/IVDR transition, CE Mark, 510(k), PMA, CER/PER, PMS/PMCF plans, and risk management — full lifecycle support.
Read More
Medical Affairs strategy, RWE/HEOR roadmaps, launch excellence, evidence synthesis, and AI/digital transformation advisory.
Read More
End-to-end payroll for life sciences teams: statutory compliance (PF, ESI, PT, TDS), contractor payouts, F&F, and expat handling.
Read More PROTOTYPE
15+ AI-powered prototype platforms across Medical Affairs, Commercial, HEOR/RWE, and R&D strategy — under active development.
Explore PrototypesEvery decision starts with patient safety and therapeutic benefit.
ICH, GVP, EU MDR, 21 CFR — uncompromising regulatory rigor.
Right-sized engagements that fit your study budget and timelines.
Clear deliverables, honest timelines, real-time status visibility.
Let's talk about how PharBioMed can support your next clinical, regulatory, or commercial milestone.
Start a Conversation →